Codexis, Inc. (CDXS) vs Korro Bio, Inc. (KRRO)
Codexis, Inc. and Korro Bio, Inc. are both Biotechnology companies. Codexis, Inc. and Korro Bio, Inc. are of similar size ($150.0M and $140.9M). Codexis, Inc. grew revenue faster over the last twelve months: 35.9% against −81.9%. Korro Bio, Inc. has the higher net margin (0.00% vs −39.6%) and the higher return on invested capital (0.00% vs −151.2%). Across the 17 metrics below, Korro Bio, Inc. leads on 9 and Codexis, Inc. on 8.
Valuation
Profitability
| Metric | CDXS | KRRO | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.02% | 100.00% | 65.16% |
| Operating margin | (35.61%) | 0.00% | 0.00% |
| Net margin | (39.55%) | 0.00% | 0.00% |
| Free cash flow margin | (15.66%) | 0.00% | 0.00% |
| Return on equity | (69.36%) | (97.69%) | (57.72%) |
| Return on assets | (23.79%) | (62.03%) | (49.22%) |
| Return on invested capital | (151.17%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack